Almost 10,000 doctors from China joining together to learn about the latest developments in anaesthesiology. Impressions of the 25th Annual Meeting of the Chinese Society of Anaesthesiology - CSA2017 - 中华医学会第25 次全国麻醉学术年会
Pharma Digital Marketing: Lackluster or Blockbuster?
Should all Women with Endocrine-Sensitive and Operable Breast Cancer Receive Adjuvant Hormonal Therapy?
ESMO 2016 Breast Cancer: Focus on CDK4/6
Pancreatic Cancer Awareness Month: What is your Risk?
Immunotherapies in cancer: What to Expect as patient
Novel Biomarker for Ipilimumab Treatment
ESMO 2016 Ipilimumab (Yervoy®) Data
ESMO 2016 Pembrolizumab (Keytruda®) Data
ESMO 2016 Durvalumab, Avelumab, and Tremelimumab Data
ESMO 2016 Atezolizumab (Tecentriq®)
ESMO 2016 Nivolumab (Opdivo®) Data
MediPaper is following the ESMO 2016 Immunotherapy Track. Sign up for our newsletter and get notified
CRUK: Cancer Symptom Awareness linked to Survival
2016 ASCO Ovarian Cancer Guidelines for Neo-Adjuvant Chemotherapy
IMM-101 Plus Gemcitabine in Metastatic Pancreatic Cancer
Remember our ASCO16 Tremelimumab data summary PowerPoint slides?
Remember our ASCO16 Durvalumab data summary PowerPoint slides?
Remember our ASCO16 Avelumab data summary PowerPoint slides?
Remember our ASCO16 Ipilimumab data summary PowerPoint slides?
Remember our ASCO16 Atezolizumab data summary PowerPoint slides?
Remember our ASCO16 Pembrolizumab data summary PowerPoint slides?
Remember our ASCO16 Nivolumab data summary PowerPoint slides?
MediPaper: Medical Blog SEO Optimisation
ASCO 2016 Ribociclib & Abemaciclib Data
ASCO 2016 Palbociclib (Ibrance™) Data
ASCO2016 Avelumab, Durvalumab and Tremelimumab
ASCO 2016 Atezolizumab (Tecentriq™) Data
ASCO 2016 Ipilimumab (Yervoy™) Data
ASCO 2016 Nivolumab (OPDIVO™) Data
MediPaper Healthcare Writers
Why Hire a Medical Writer Agency?
About our Medical Writer Agency
Medical Writing Solutions | 醫學寫作
Medical Writing Quote
Medical Writing Impressions
Medical Writer Hong Kong | 醫學作家香港
Hire Healthcare Writers Hong Kong
Contact a Medical Writer
Medical Communications Blog
Medical Writer Jobs
MEDIPAPER MEDICAL COMMUNICATIONS LTD
Unit 1104, 11/F, Crawford House
70 Queen’s Road Central
Hong Kong SAR
(852) 3008 1717
- Dramatic Improvement in NHL Outcomes With CAR T-Cell Versus Standard Therap... September 20, 2017Treatment with the autologous anti-CD19 CAR T-cell therapy axicabtagene ciloleucel significantly improved outcomes in refractory non-Hodgkin lymphoma compared with standard therapies.
- Cabozantinib, Nivolumab Active in Metastatic Urothelial Carcinoma September 20, 2017Cabozantinib and nivolumab with or without ipilimumab show activity in genitourinary tumors, particularly urothelial carcinoma, and have manageable safety profiles.
- Facebook trial lets users hide alcohol adverts September 20, 2017The social network is testing a tool that will let people hide categories of ads for the first time.
- CAR T-Cell Therapy Active in High-Risk, Refractory CLL September 20, 2017Patients with refractory chronic lymphocytic leukemia achieved a high-response rate with CD19-targeted CAR T-cell therapy JCAR014.
- Fracture Risk Higher for Seniors With Diabetes September 20, 2017Bone weaknesses seen in those with blood sugar disease